BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 12968132)

  • 41. Repeated amphetamine administration alters the expression of mRNA for AMPA receptor subunits in rat nucleus accumbens and prefrontal cortex.
    Lu W; Chen H; Xue CJ; Wolf ME
    Synapse; 1997 Jul; 26(3):269-80. PubMed ID: 9183816
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Selective enhancement of mesocortical dopaminergic transmission by noradrenergic drugs: therapeutic opportunities in schizophrenia.
    Masana M; Bortolozzi A; Artigas F
    Int J Neuropsychopharmacol; 2011 Feb; 14(1):53-68. PubMed ID: 20701825
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The non-peptidic delta opioid receptor agonist TAN-67 enhances dopamine efflux in the nucleus accumbens of freely moving rats via a mechanism that involves both glutamate and free radicals.
    Fusa K; Takahashi I; Watanabe S; Aono Y; Ikeda H; Saigusa T; Nagase H; Suzuki T; Koshikawa N; Cools AR
    Neuroscience; 2005; 130(3):745-55. PubMed ID: 15590157
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stress-induced activation of ventral tegmental mu-opioid receptors reduces accumbens dopamine tone by enhancing dopamine transmission in the medial pre-frontal cortex.
    Latagliata EC; Valzania A; Pascucci T; Campus P; Cabib S; Puglisi-Allegra S
    Psychopharmacology (Berl); 2014 Oct; 231(21):4099-108. PubMed ID: 24958228
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Maternal high-fat intake alters presynaptic regulation of dopamine in the nucleus accumbens and increases motivation for fat rewards in the offspring.
    Naef L; Moquin L; Dal Bo G; Giros B; Gratton A; Walker CD
    Neuroscience; 2011 Mar; 176():225-36. PubMed ID: 21187125
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The dopamine beta-hydroxylase inhibitor nepicastat increases dopamine release and potentiates psychostimulant-induced dopamine release in the prefrontal cortex.
    Devoto P; Flore G; Saba P; Bini V; Gessa GL
    Addict Biol; 2014 Jul; 19(4):612-22. PubMed ID: 23289939
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differences in dopamine responsiveness to drugs of abuse in the nucleus accumbens shell and core of Lewis and Fischer 344 rats.
    Cadoni C; Di Chiara G
    J Neurochem; 2007 Oct; 103(2):487-99. PubMed ID: 17666048
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential activation of dopamine release in the nucleus accumbens core and shell after acute or repeated amphetamine injections: a comparative study in the Roman high- and low-avoidance rat lines.
    Giorgi O; Piras G; Lecca D; Corda MG
    Neuroscience; 2005; 135(3):987-98. PubMed ID: 16154292
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Post-pubertal emergence of a dopamine phenotype in netrin-1 receptor-deficient mice.
    Grant A; Speed Z; Labelle-Dumais C; Flores C
    Eur J Neurosci; 2009 Oct; 30(7):1318-28. PubMed ID: 19788579
    [TBL] [Abstract][Full Text] [Related]  

  • 50. S-(N, N-diethylcarbamoyl)glutathione (carbamathione), a disulfiram metabolite and its effect on nucleus accumbens and prefrontal cortex dopamine, GABA, and glutamate: a microdialysis study.
    Faiman MD; Kaul S; Latif SA; Williams TD; Lunte CE
    Neuropharmacology; 2013 Dec; 75():95-105. PubMed ID: 23891816
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activation of GABA-B receptors induced by systemic amphetamine abolishes dopamine release in the rat lateral septum.
    Sotomayor-Zárate R; Araya KA; Pereira P; Blanco E; Quiroz G; Pozo S; Carreño P; Andrés ME; Forray MI; Gysling K
    J Neurochem; 2010 Sep; 114(6):1678-86. PubMed ID: 20584106
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of adolescent social defeat on adult amphetamine-induced locomotion and corticoaccumbal dopamine release in male rats.
    Burke AR; Forster GL; Novick AM; Roberts CL; Watt MJ
    Neuropharmacology; 2013 Apr; 67():359-69. PubMed ID: 23220295
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mouse strain differences in locomotor, sensitisation and rewarding effect of heroin; association with alterations in MOP-r activation and dopamine transporter binding.
    Bailey A; Metaxas A; Al-Hasani R; Keyworth HL; Forster DM; Kitchen I
    Eur J Neurosci; 2010 Feb; 31(4):742-53. PubMed ID: 20384817
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Strain differences in basal and cocaine-evoked dopamine dynamics in mouse striatum.
    He M; Shippenberg TS
    J Pharmacol Exp Ther; 2000 Apr; 293(1):121-7. PubMed ID: 10734161
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of short-term abstinence from escalating doses of D-amphetamine on drug and sucrose-evoked dopamine efflux in the rat nucleus accumbens.
    Vacca G; Ahn S; Phillips AG
    Neuropsychopharmacology; 2007 Apr; 32(4):932-9. PubMed ID: 16885936
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Supersensitivity to amphetamine in protein kinase-C interacting protein/HINT1 knockout mice.
    Barbier E; Zapata A; Oh E; Liu Q; Zhu F; Undie A; Shippenberg T; Wang JB
    Neuropsychopharmacology; 2007 Aug; 32(8):1774-82. PubMed ID: 17203012
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stimulation of in vivo dopamine transmission and intravenous self-administration in rats and mice by JWH-018, a Spice cannabinoid.
    De Luca MA; Bimpisidis Z; Melis M; Marti M; Caboni P; Valentini V; Margiani G; Pintori N; Polis I; Marsicano G; Parsons LH; Di Chiara G
    Neuropharmacology; 2015 Dec; 99():705-14. PubMed ID: 26327678
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dopamine depletion in the medial prefrontal cortex induces sensitized-like behavioral and neurochemical responses to cocaine.
    Beyer CE; Steketee JD
    Brain Res; 1999 Jul; 833(2):133-41. PubMed ID: 10375688
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacological Modulation of 5-HT
    Browne CJ; Ji X; Higgins GA; Fletcher PJ; Harvey-Lewis C
    Neuropsychopharmacology; 2017 Oct; 42(11):2178-2187. PubMed ID: 28720903
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Restricted eating with weight loss selectively decreases extracellular dopamine in the nucleus accumbens and alters dopamine response to amphetamine, morphine, and food intake.
    Pothos EN; Creese I; Hoebel BG
    J Neurosci; 1995 Oct; 15(10):6640-50. PubMed ID: 7472425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.